| Literature DB >> 32922883 |
Yunchol Pak1, Xuejun Yang2, Yongdok Kim1, Chanhong Jong1, Haksong Kim1, Namhyok Lee1, Songgun Kim1, Yongchol Kim1.
Abstract
BACKGROUND: A pituitary tumor is a tumor with a high incidence among brain tumors. Microscopic traditional STT approach with aid of endoscope has a high therapeutic effect and few complications.Entities:
Keywords: Complication; Endoscopic; Pituitary surgery; STT approach; Sellar
Year: 2018 PMID: 32922883 PMCID: PMC7398249 DOI: 10.1186/s41016-018-0130-y
Source DB: PubMed Journal: Chin Neurosurg J ISSN: 2057-4967
Pathology
| Group | Non-functioning | GH | Prolactin | ACTH | Mixed | Etc |
|---|---|---|---|---|---|---|
| Control ( | 45 (42.9) | 25 (23.8) | 5 (4.8) | 2 (1.9) | 3 (2.8) | 25 (23.8) |
| Study ( | 16 (40.0) | 14 (35.0) | 5 (12.5) | 1 (2.5) | 4 (10.0) |
Fig. 1Coronal and sagittal MRI images of a patient who underwent a STT approach a. MRI image before surgery, showing a large pituitary adenoma extending suprasellar area and compressing the optic chiasm upward, b. MRI image 6 month later STT surgery showing fat grafts in the sella turcica and sphenoid sinus. The diaphragm sellae has descended into the sellar cavity and revealed complete disappearance of the tumor in the sellar and suprasellar region
Fig. 2Removal of the tumor and pathological studies. a: Insertion of Hardy speculum to the sphenoidal bone. b: Confirm of ostium of sphenoidal sinus and removal of sphenoidal bone. c: Confirm of sellar floor. d: Removal of sphenoidal floor and exposure of sellar dura. e: The sellar dura was opened with a cruciate incision. f: Image after tumor removal. g, h: Pathological studies: multifunctional adenoma;PRL(+), GH(+), TSH(++)(g: hematoxylin and eosin staining, original magnification, *200. h: hematoxylin and eosin staining, original magnification, *400)
Size of tumor
| Group | ~ 9 | 10~ 19 | 20~ 29 | 30~ 39 | 40~ 49 | 50~ 59 | 60~ 69 | 70~ 79 |
|---|---|---|---|---|---|---|---|---|
| Control ( | 8(7.5) | 12(11.3) | 54(50.9) | 26(24.5) | 4(3.8) | 2(1.9) | ||
| Study ( | 1(2.5) | 5(12.5) | 8(20.0) | 17(42.5) | 5(12.5) | 1(2.5) | 1(2.5) | 2(5.0) |
Tumor removal grade
| Group | Total removal | Subtotal removal | Partial removal |
|---|---|---|---|
| Control( | 75(70.8) | 16(15.1) | 15(14.1) |
| Study(=40) | 33(82.5)** | 3(7.5) | 4(10.0) |
**(p < 0.01)
Change of visual acuity
| Group | The number of defected eye Before surgery | The number of improved eye After surgery |
|---|---|---|
| Control( | 138(100.0) | 112(81.1) |
| Study ( | 56(100.0) | 46(82.1) |
n: The number of eye
Change of visual field
| Group | The number of defected eye Before surgery | The number of improved eye After surgery |
|---|---|---|
| Control( | 144(100.0) | 116(80.5) |
| Study ( | 64(100.0) | 52(81.2) |
n:The numberof eye
Therapy efficiency
| Group | Cure | Good | No change | Worse | Death | Efficacy (%) |
|---|---|---|---|---|---|---|
| Control ( | 78(73.6) | 20(18.9) | 5(4.7) | 1(0.9) | 2(1.9) | 92.5 |
| Study ( | 35(87.5) | 4(10.0) | 1(2.5) | 97.5* |
*(p < 0.05)
Postoperative complication
| Group | Rhinorrhea | Meningitis | Septal perforation |
|---|---|---|---|
| Control( | 1(0.94) | 1(0.94) | 1(0.94) |
| Study(=40) | 0(0.0) | 0(0.0) | 0(0.0) |